Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas

Clinical trial NCT05105412 · TERMINATED

Trial details

NCT number: NCT05105412
Sponsor: National Health Research Institutes, Taiwan
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peripheral T-cell Lymphomas (PTCL)

Start date: 2022-06-15
Primary completion: 2024-03-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.